Those numbers show something important: the difference is small, not structural
Fun fact: the FDA does not consider a medication commercially available if there is a shortage of that medication
These outcomes were categorized into endocrine and metabolic outcomes, cardiovascular outcomes, cancer outcomes, renal outcomes, respiratory outcomes, mortality and AEs, and other outcomes
The DAC version binds albumin and stays active for 6-8 days, producing sustained GH and IGF-1 elevation
Broader implications for compulsive behaviors Tirzepatide binds to receptors in the ventral tegmental area, nucleus accumbens, and prefrontal cortex, all brain regions central to reward processing and impulse control